Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
27
Number of overlapping holdings
20.9%
% of XBI's 129 holdings also in IDNA
60.0%
% of IDNA's 61 holdings also in XBI
Overlap by Weight
Sector Drift (XBI minus IDNA)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in XBI |
Weight in IDNA |
Overlap | |
|---|---|---|---|---|
 |
GILEAD SCIENCES INC | 3.2% | 5.0% | 3.2% |
|
REGENERON PHARMACEUTICALS | 2.8% | 4.5% | 2.8% |
|
SAREPTA THERAPEUTICS INC | 2.4% | 4.0% | 2.4% |
|
INCYTE CORP | 2.4% | 4.2% | 2.4% |
|
EXELIXIS INC | 1.3% | 4.7% | 1.3% |
Position Highlights (Non-Overlapping Exposures)
XBI Overweight Relative to IDNA
|
EXACT SCIENCES CORP | 3.9% |
|
VIKING THERAPEUTICS, INC. | 3.0% |
|
UNITED THERAPEUTICS CORP | 3.0% |
|
ALNYLAM PHARMACEUTICALS INC | 2.9% |
|
ABBVIE INC | 2.9% |
|
NATERA INC | 2.8% |
|
AMGEN INC | 2.8% |
|
BIOMARIN PHARMACEUTICAL INC | 2.5% |
|
VERTEX PHARMACEUTICALS INC | 2.5% |
|
BIOGEN IDEC INC | 2.1% |
XBI Underweight Relative to IDNA
 |
BEIGENE, LTD. | -5.0% |
 |
BIONTECH SE SPONSORED ADR | -4.8% |
 |
SANOFI-AVENTIS | -4.6% |
 |
ROCHE HOLDING LTD | -4.5% |
 |
TAKEDA PHARMACEUTICAL CO LTD | -4.3% |
 |
GSK PLC | -4.1% |
 |
GENMAB A/S | -3.8% |
|
EXELIXIS INC | -3.5% |
|
MERCK & CO. INC. | -3.5% |
|
REVOLUTION MEDICINES, INC. | -3.2% |